Clinical Trial: QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07441317) titled 'QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)' on Feb. 11.

Brief Summary: To evaluate the efficacy, safety and immunogenicity of QCL7401 subcutaneous administration in patients with primary hypercholesterolemia or mixed hyperlipidemia with poorly controlled LDL-C elevated on optimized lipid-lowering therapy.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Primary Hypercholesterolemia or Mixed Hyperlipidemia

Intervention: DRUG: QLC7401

QLC7401 combined with lipid-lowering agents

DRUG: Placebo

Placebo combined with...